Meetings and Coursee

Meetings and Coursee

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the Hepatobiliary & Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

April， 2017

The international liver congress™ 2017

April 19-23， 2017; Amsterdam， Netherlands

The international liver congress (ILC) 2017 provides a unique opportunity for clinicians and scientists from all over the world to meet not only to discuss clinical innovation and research challenges but also to interact socially， network and develop future collaborations. The 2017 ILC highlights comprise: 1) Post graduate course entitled “A multidisciplinary approach to patients with liver disease”; 2) State of the art lectures on liver transplantation for HCC and cell growth control in cancer therapy; 3) Basic science seminar on hepatic regenerative medicine; 4) Late breaker session; 5) Clinical Grand Rounds and symposia; 6) EASL Clinical Practice Guidelines sessions; 7) Fusion session; and 8) Young Investigators Forum and symposium. Selected sessions and posters will be webcasted and made available on the LiverTree™ for EASL members to view. For more information， please visit: website: https://ilc-congress.eu/.

European digestive surgery (EDS) 2017

April 27-29， 2017; Budapest， Hungary

The 11th European digestive surgery (EDS) postgraduate course will be held in Budapest， Hungary， on April 27-29， 2017. The EDS initial objective is to encourage the development and expansion of high quality surgical profession and to promote education in this field. This two-day postgraduate course can help attendees to learn more novelties from the surgery of the gastrointestinal tract. For more information， please contact: Scientific Committee， European Digestive Surgery Department of General Surgery， Technical University of Munich， Ismaninger Strasse 22， 81675 Munich， Germany. Tel: +49-89-4140-2123; Fax: +49-89-4140-4870;Email:secretary edsurgery.oorrgg;; Website: http://www.eds2017.org/.

May 24-27， 2017; Prague Congress Center， Czech Republic

The 2017 joint international congress of ILTS， ELITA & LICAGE will be held on May 24-27， 2017 at the Prague Congress Centre. Over 1200 professionals from over 40 countries who are dedicated to promoting and learning about the scientific advances in liver transplantation are brought together to discuss the latest advances in liver transplantation procedures and therapy. The goal of this congress is to broaden the education of scientists， surgeons， anesthesiologists， physicians， nurses， and organ procurement personnel in the care and treatment of liver transplant patients. For further information， please contact: ILTS 2017 Registration Department， Allison Jansen， Tel: +49-30-24603-410; Email: ilts2017registration kit-kitgroup.org; website: http://2017.ilts.org/.

May

2017 joint international congress of ILTS， ELITA & LICAGE

June

Cholangiocytes in health and disease: from basic science to novel treatments

June 9-11， 2017; Oslo， Norway

The conference will address major novel findings on the pathophysiology of biliary diseases and bile acid metabolism; implications of the gains in knowledge on the current and future clinical practice will be discussed. It will be the perfect venue for young scientists and clinicians to present their work and listen to key opinion leaders about what will be important in science and in clinics in the coming years. Participants will learn about the development of the biliary tree， morphological features of cholangiocytes and their role in normal liver physiology and in the metabolism/homeostasis of bile acids. Moreover， the clinical features of cholangiopathies and the molecular mechanism triggering their development will be covered in detail， as well as new emerging diagnostic and therapeutic tools， biliary tree， anatomy and 3D structure， bioengineering， cholangiocyte pathophysiology， immunity， genetics， carcinogenesis， cholangiocarcinoma， clinical practice， biomarkers， and diseases management. For more information， please visit: http://www.EASL.eu/l.eu/ discover/events/detail/2017/cholangiocytes-in-healthand-disease-from-basic-science-to-novel-treatments.

3rd EACR conference on cancer genomics

June 25-28， 2017; Cambridge， United Kingdom

The 3rd EACR conference on cancer genomics is the premier European conference dedicated to cancer genomics. It will update you on the latest exciting developments: cancers as communities of clones and communities of cells， liquid biopsies， genomics and cancer immunology，mutational processes， and genomic and immune system landscapes of human cancers. Topics include: 1) Immunology in the age of single cell genomics; 2) Oncomicrobiota; 3) Towards deciphering the functional genetic and neo antigenic landscape in cancer; 4) T cell recognition of human cancer; 5) Exploiting acquired vulnerabilities of drug resistant tumours; 6) Precision medicine; 7) Clonal and cellular heterogeneity landscapes of cancer; 8) Role of rare mutations in the onset of cancer; 9) Tumour genomes shed light into mutational processes and cancer vulnerabilities; 10) Molecular analysis of circulating tumour cells; 11) Inferring expressed genes by whole-genome sequencing of plasma DNA; 12) Predicting relapse using circulating tumour DNA; 13) Patient-derived primary cancer cells， integrative omics and functional drug testing; and 14) Tracking cancer evolution. Cancer genomics 2017 will be relevant to participants from across a number of fields including cancer medicine， cancer biology， translational research， bioinformatics， epigenomics， cancer immunology and molecular pathology. Importantly， early career researchers will have the opportunity to present their work to the international community. For more information， please visit: https://www.eacr.org/conference/cancergen omics2017?utm_source=genomics17listing. visit: http://oncoic.org/.

Oncologic imaging course 2017

June 29-July 1， 2017; Dubrovnik， Croatia

Organized by Memorial Sloan Kettering Cancer Center， Medizinische Universität Wien， and LMU Klinikum der Universität München， this course is to be held at Dubrovnik， Croatia on June 29-July 1， 2017. The objectives of this course are: 1) Provide up-to-date reviews on the use of imaging to detect， characterize and stage common tumors; 2) Illustrate the various newer systems for imaging response assessment in use today; 3) Emphasize the basic principles of interpreting and reporting oncologic imaging examinations; 4) Provide an extended， indepth review of best practices in breast imaging; 5) Present hot topics and emerging applications; 6) Utilize interactive teaching and problem-solving case presentations; and 7) Employ workshops to allow additional interaction with the faculty. For more information， please

July

Infectious diseases summit

July 13-14， 2017; Baltimore， United States

Infectious diseases summit will take place on July 13-14， 2017 in Baltimore， MD， USA. This event seeks to provide a forum for leaders to get the most comprehensive and wide-reaching perspective on issues， challenges， and advances in the field. Recent developments in the space has signaled the landscape of infectious diseases is shifting: Why is there a renewed interest in this field? What will it mean for biotech companies， government agencies， and other players? This summit seeks to highlight all stages of the field， from research and novel therapeutics， to commercialization aspects and market activity. The summit begins with the plenary session on responding to emerging infectious diseases on the global stage and disperses into the following three conferences: 1) 6th antiviral drugs research & development: respiratory viral infections: current landscape and emerging drugs; blood borne pathogens: new frontiers in research and drug development; challenges in clinical study design and considerations; panel: new approaches to antiviral development; 2) 15th vaccines research & development: vaccines for infectious diseases-old & new challenges; next-generation vaccine technologies; enhancing immunity at both ends of the age spectrum; panel: clinical trial design during epidemics; 3) 14th anti-infectives partnering & deal-making: non-traditional approaches and technologies in anti-infectives; regulatory considerations for drug development; economic drivers moving drug development forward; panel: funding & partnering with US government agencies; panel: pricing and P&T committee’s role in determining novel antibiotic usage; panel: pushing and pulling-what incentives help spark innovation in antibiotic drug discovery and development? For more information， please visit: http://www. gtcbio.com/conferences/infectious-diseases-summit/.

10.1016/S1499-3872(17)60004-3)